Journal
JOURNAL OF NATURAL MEDICINES
Volume 73, Issue 2, Pages 388-396Publisher
SPRINGER JAPAN KK
DOI: 10.1007/s11418-018-01275-3
Keywords
Andrographolide; Cholestatic liver injury; Inflammation; Oxidative stress
Categories
Funding
- National Natural Science Foundation of China [81473504]
- China Scholarship Council [201708080032]
Ask authors/readers for more resources
To investigate if andrographolide impairs cholestatic liver injury. All rats were randomly divided into six groups(1) control (n=6), (2) control+200mg/kg andrographolide (n=6), (3) alpha-naphthylisothiocyanate (ANIT)-control (n=6), (4) ANIT+50mg/kg andrographolide (n=6), (5) ANIT+100mg/kg andrographolide (n=6), and (6) ANIT+200mg/kg andrographolide (n=6). We gavaged 50mg/kg ANIT to mimic cholestatic liver injury in rats. Seven days after treatment, all the rats were killed. Serum biochemistry and hepatic histopathological assays were performed to evaluate liver injury. We observed that 200mg/kg andrographolide significantly decreased the level of alanine transaminase, aspartate aminotransferase, alkaline phosphatase, -glutamyltranspeptidase, total bilirubin, and total bile acid in the blood. It also markedly decreased hepatic interleukin-6 and tumor necrosis factor . Furthermore, 200mg/kg andrographolide significantly decreased malondialdehyde but increased superoxide dismutase, glutathione, and erythrocyte glutathione peroxidase. Moreover, 200mg/kg andrographolide effectively increased the accumulation of sirtuin 1 and nuclear erythroid 2-related factor-2. It also attenuated the level of nuclear factor kappa-light-chain-enhancer of activated B and cyclooxygenase-2. These data suggest that andrographolide may impair cholestatic liver injury via anti-inflammatory and anti-oxidative stress.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available